GlobeNewswire Inc.··Robbins LlpImmutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit
Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.
IMMPclass action lawsuitmisleading statements